Robert Wills

Dr. Robert J.
Wills is an Independent Director at Alpha Cognition, Inc., a Chairman at Milestone Pharmaceuticals, Inc. and an Independent Director at Oncternal Therapeutics, Inc. He is on the Board of Directors at Alpha Cognition, Inc., Oncternal Therapeutics, Inc., Go Therapeutics, Inc., Parion Sciences, Inc. and Feldan Bio, Inc. Dr. Wills was previously employed as a Member-Emerging Companies Section by Biotechnology Innovation Organization, a Chairman by CymaBay Therapeutics, Inc., an Executive Chairman by GTx, Inc., a Vice President-Alliance Management by Janssen Pharmaceuticals, Inc., and a Senior Vice President-Global Development by Johnson & Johnson.
He also served on the board at Oncternal Oncology, Inc. He received his undergraduate degree from the University of Wisconsin, a graduate degree from the University of Wisconsin and a doctorate degree from The University of Texas at Austin.